Intervention to Change Affect Recognition and Empathy
Public ClinicalTrials.gov record NCT05636020. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Intervention to Change Affect Recognition and Empathy (ICARE)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Determine the feasibility, practicality, and early efficacy of a TeleRehab program (ICARE) to improve outcomes for persons with traumatic brain injury (TBI) in recognizing and responding to others' emotions alongside their care partner (CP).
Study identification
- NCT ID
- NCT05636020
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 85 participants
Conditions and interventions
Conditions
- Traumatic Brain Injury
- Concussion, Intermediate
- Concussion, Severe
- Concussion With LOC 31 to 59 Minutes
- Concussion With Brief Loss of Consciousness
- Traumatic Brain Injury With Brief Loss of Consciousness
- Traumatic Brain Injury With Loss of Consciousness
- Traumatic Brain Injury With Prolonged Loss of Consciousness
- Traumatic Brain Injury (TBI); Concussion, Initial Encounter
- Traumatic Brain Injury (TBI); Concussion, Subsequent Encounter
- Traumatic Brain Injury With No Loss of Consciousness
- Traumatic Brain Injury With Open Intracranial Wound
- Traumatic Brain Injury With Moderate Loss of Consciousness
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 14, 2023
- Primary completion
- Jan 31, 2027
- Completion
- Jan 31, 2027
- Last update posted
- Aug 5, 2026
2023 – 2027
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Indiana University School of Medicine | Indianapolis | Indiana | 46254 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05636020, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 5, 2026 · Synced Sep 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05636020 live on ClinicalTrials.gov.